Mr. Oliver O'Connor:

Of course companies have a moral and ethical responsibility and they are very conscious of it. The first way to discharge that is to use what they do to pursue it properly and with standards of excellence, which in the first place is to discover and apply and do research to the highest standards of excellence possible to discover the solutions we want. Two years ago, there were no vaccines. Companies made strong ethical commitments to devote all their resources - every possible one they could - to making that discovery and to organising their global manufacturing processes to deliver the vaccines. That is a very high ethical obligation. Therefore, companies do that and they are very conscious of those obligations. As I said to the committee previously, the question of the balance of reward and value is one that is thought about constantly. It happens in dialogue daily with our public sector, including with the HSE and the National Centre for Pharmacoeconomics. It happens at a global level as well. People are very conscious of their obligations and their role in society.